{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/13/3344388/0/en/liminatus-pharma-announces-transfer-to-nasdaq-capital-market-and-extension-to-regain-compliance-with-minimum-bid-price-requirement.html", "message": "News view counter 880633 successfully enlarged"}